LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 213 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $1,360,000 | -8.8% | 8,921 | -40.5% | 0.01% | 0.0% |
Q4 2020 | $1,492,000 | +5.7% | 15,004 | +1.4% | 0.01% | 0.0% |
Q3 2020 | $1,411,000 | -4.5% | 14,804 | +12.1% | 0.01% | -16.7% |
Q2 2020 | $1,477,000 | +30.1% | 13,204 | -15.4% | 0.01% | +20.0% |
Q1 2020 | $1,135,000 | -20.0% | 15,604 | +14.7% | 0.01% | 0.0% |
Q4 2019 | $1,419,000 | -8.0% | 13,604 | -12.3% | 0.01% | +11.1% |
Q3 2019 | $1,543,000 | -16.1% | 15,504 | -3.7% | 0.01% | -30.8% |
Q2 2019 | $1,838,000 | +120.9% | 16,104 | +143.2% | 0.01% | +116.7% |
Q1 2019 | $832,000 | -10.2% | 6,621 | -2.9% | 0.01% | -25.0% |
Q4 2018 | $926,000 | -52.6% | 6,821 | -4.1% | 0.01% | -46.7% |
Q3 2018 | $1,952,000 | +30.6% | 7,113 | -1.4% | 0.02% | +50.0% |
Q2 2018 | $1,495,000 | -2.8% | 7,213 | -22.5% | 0.01% | 0.0% |
Q1 2018 | $1,538,000 | – | 9,313 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knott David M Jr | 115,000 | $7,682 | 2.90% |
VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |